| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |